FTC Settlement Could Save Americans $7B on Insulin
A landmark settlement with pharmacy giant Express Scripts will force major changes that could save Americans up to $7 billion on insulin costs over the next decade. The Federal Trade Commission says the company artificially inflated prices and blocked access to the lifesaving diabetes medication.
